Ezh2 Inhibitors Reverse Resistance to Gefitinib in Primary Egfr Wild-type Lung Cancer Cells

Hao Gong(Guangxi University), Jun Chen(Fourth People's Hospital of Taiyuan)
Research Square
June 11, 2020
Cited by 1


Related Papers